http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-2805805-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ae2afa937c0bfa5a9836926c06bd4911
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-40
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D235-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4184
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4184
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
filingDate 2011-02-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_98a1eea565ddbf68aa1de176d34be7fc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_853a7b2da7f588621bc26e1c79668cf6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_00fc9f46a0f567351fb94d9d98779457
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cdc9bd0c82a6c926494c1b04a45c53db
publicationDate 2012-09-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CA-2805805-A1
titleOfInvention Bendamustine anionic-catioinic cyclopolysaccharide compositions
abstract The present invention is directed to pharmaceutical compositions including: (a) bendamustine, (b) a first charged cyclopolysaccharide, and (c) a stabilizing agent which is a second charged cyclopolysaccharide having a charge opposite to that of the first charged cyclopolysaccharide. The composition provides unexpectedly desirable stability in reactive environments such as plasma, coupled with unexpectedly desirable anticancer activity. The compositions are suitable for injection or infusion into patients in need for treatment with bendamustine.
priorityDate 2010-07-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID70471
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559377
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID223
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5360545
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3520
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559564
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID65628
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID77082
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419572902
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID412584818
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454526095
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559553
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419582371
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457814461
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID444041
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16683004
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5287407
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID444913
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1117
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419540045
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3763
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419583841
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415152033
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419500386
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419507060

Total number of triples: 47.